Novast (301569.SZ) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 301569.SZ's market cap?

Novast (301569.SZ) has a market capitalization of approximately ¥16.42 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

Does 301569.SZ pay a dividend?

No, Novast (301569.SZ) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

301569.SZ (Novast) is a recent IPO.

It began trading on October 15, 2026, giving it less than a month of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates. The affected sections are flagged individually so you can tell limited history from missing data.

301569.SZ

Novast

SHZ·Medical, Pharmaceuticals · Healthcare

¥18.42¥0.92+5.26%

Market cap¥16.42B·Market closed·Oct 23 3:04 AM EDT

Price Chart

¥18.42+¥0.92 (+5.26%)today

−47.55%

Select date range

FromTo

Oct 15, 2026Oct 15, 2026 → Oct 24, 2026· 9 daysOct 24, 2026

Key Metrics

301569.SZ does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how 301569.SZ's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 301569.SZ and 80,000+ other tickers.

About Novast

NOVAST Laboratories, Limited develops, manufactures, and sells prescription drug formulations. The company produces controlled-release formulations, including extended-release and sustained-release tablets and capsules, as well as low-dose drug formulations. Its products include Metoprolol Succinate Extended-Release Tablets, Nifedipine Extended-Release Tablets, Diltiazem Hydrochloride Extended-Release Capsules, Metformin Hydrochloride Sustained-Release Tablets, Levonorgestrel Tablets, Memantine Hydrochloride Extended-Release Capsules, Quetiapine Fumarate Sustained-Release Tablets, and…

CEO: Guo Hua Zhang
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: SHZ
Employees: 697
Website: www.novast.cn

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 301569.SZ

What does Novast do?: Novast (301569.SZ) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 301569.SZ's market cap?: Novast (301569.SZ) has a market capitalization of approximately ¥16.42 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.
Does 301569.SZ pay a dividend?: No, Novast (301569.SZ) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.